止咳平喘类中成药中9种非法添加化学成分的定性定量检验方法研究

来源 :广州中医药大学学报 | 被引量 : 0次 | 上传用户:lzj509649444
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
【目的】建立检测止咳平喘中成药中9种非法添加化学成分的定性定量检验方法。【方法】采用超高效液相色谱—四级杆—飞行时间串联质谱(UPLC-Q-TOF)联用技术对止咳平喘类中成药中非法添加的9种化学成分进行定性筛查,经筛查为阳性的样品用高效液相色谱法(HPLC)对止咳平喘中成药中非法添加的9种化学成分进行含量检测。色谱柱采用Kromasil C18(250 mm×4.6 mm,5μm),流动相为乙腈及甲酸铵缓冲液(p H 3.65),梯度洗脱,流速为1.0 m L/min,检测波长为225 nm和280 nm。【结果】通过对5批止咳平喘类中成药进行检测,检出1批样品含有磷酸可待因,含量为0.84 mg/m L。【结论】本法简便准确,灵敏度高,适用于止咳平喘类中成药中9种非法添加化学成分的检测。 【Objective】 To establish a qualitative and quantitative test method to detect nine kinds of illicitly added chemical constituents in proprietary Chinese medicines for relieving cough and asthma. 【Method】 Nineteen chemical constituents illegally added to proprietary Chinese medicines for relieving cough and asthma were qualitatively screened by UPLC-Q-TOF combined with ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry Positive samples were detected by high performance liquid chromatography (HPLC) on cough and asthma patent medicines illegally added to the content of nine chemical constituents. The column was eluted with a gradient of Kromasil C18 (250 mm × 4.6 mm, 5 μm) with acetonitrile and ammonium formate buffer (p H 3.65) at a flow rate of 1.0 mL / min at 225 nm and 280 nm . 【Result】 Five batches of cough and asthma-type Chinese patent medicines were tested. One batch of samples containing codeine phosphate was detected, with a content of 0.84 mg / m L. 【Conclusion】 This method is simple, accurate and sensitive. It is suitable for the detection of 9 kinds of illicitly added chemical constituents in proprietary Chinese medicines for relieving cough and asthma.
其他文献
目的 探讨T淋巴瘤侵袭转移诱导因子1(Tiam 1)在胃癌组织、癌旁组织、胃良性病变组织中的表达水平,及其与胃癌转移等生物学行为的关系.方法 用实时荧光定量逆转录PCR(FQ-RT-PCR)方法,对66例胃癌患者的癌组织、癌旁组织及11例胃良性病变患者的组织标本中Tiam1 mRNA进行定量检测.结果 66例胃癌患者的癌组织、癌旁组织中Tiam1 mRNA表达阳性率分别为92.4%、19.7%,1
目的 克隆人天冬酰胺合成酶(ASNS)基因,以基因工程技术表达ASNS融合蛋白,免疫动物,制备及鉴定鼠抗人ASNS的单克隆抗体,为深入研究L-天冬酰胺酶治疗中线鼻型自然杀伤细胞(NK)/T细胞淋巴瘤的机制奠定基础.方法 用逆转录(RT)-PCR从人肝癌细胞株HepG2扩增目的片段,构建原核表达质粒pMS-ASNS,在大肠杆菌中表达融合蛋白MS2-ASNS.用纯化融合蛋白免疫雌性BALB/C小鼠,以